[{"title": "Immuneering Corporation (IMRX) Tops Q2 EPS by 2c - StreetInsider", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQVnpWaVphNG0teHZoY0pBQlozWW0tOHlSWXF4TjQ3VDlTQkoyQ1JJS3FBblFHSTR6Z0Z2RHRnNDh1RHNJb094Ykd0Q29rLWltckZaYk5YcVhUUFVzYzZibDBaTG0zMjZzRmd1THdPazQwYlBtczZKSVpRWGVCeEViMngtUlVOY1ItdzJqYk9yQWJyVDNDeHVSSGFQNEJGNFRiOE4wX2R0YlQ?oc=5\" target=\"_blank\">Immuneering Corporation (IMRX) Tops Q2 EPS by 2c</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">StreetInsider</font>", "publishedAt": "Wed, 13 Aug 2025 22:02:24 GMT"}, {"title": "What hedge funds are buying Immuneering Corporation - 2025 Bull vs Bear & Long-Term Growth Stock Strategies - thegnnews.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbjlORkt4NjduQkVQX0pqTEFTa0JydW9DYVZvak9CMUdNT0JteWpEN3J3NjVVV01QWmloWmY3Y2V0SmJ3RnEtanQ4VlpEVmc0YWVTRzBuVkg5emJmSGJJaGZ0Ulg4Y3JCd1hxVG1STzRIcDAyTVRsQklCZEpWZkZWSXJ4akhpRVBXWHE4?oc=5\" target=\"_blank\">What hedge funds are buying Immuneering Corporation - 2025 Bull vs Bear & Long-Term Growth Stock Strategies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">thegnnews.com</font>", "publishedAt": "Fri, 15 Aug 2025 01:58:38 GMT"}, {"title": "Immuneering Corp. Reports Strong Trial Results and Patent Win - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQWFRYOWFwbnhWTk43MVBaX1AtSDhQVkN6RG9WX1FaQ0sxVlhRNUswaW1pWUVkcEtCM184SFpSYTVLSUdDYVVjQ2JTUGxTVll6M3lWMnVoVE1zaVNVbUxGUTNnOTlXbENvMlJIblBNeGhkM0RyVzRBcEpLemdtcy1BNlhibzJHRmgwbnlhVFNhbEd2elNIanp1NHhuWV80Z2owbVdXT1RHajdJOW9LREtRTDVn?oc=5\" target=\"_blank\">Immuneering Corp. Reports Strong Trial Results and Patent Win</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Thu, 14 Aug 2025 04:07:43 GMT"}, {"title": "Press Release: Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates - \u5bcc\u9014\u725b\u725b", "description": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxOMmdicFhSSHdNT3A1REhVMDk2VjAzNTVDX25XbWZBN05pWkN4ekFPTFpqSWhrS010SXBUVDZLZzFISWU5RHJSTkdaRld4M0xlVlIybkpLYjZkTDR6ZDNmUzdaT3RmQkdfaFVncEZjRFBSQXUwS3A1bFJ0TkhLellXcWZqMFVlOU9CblE4NlBfZWpnU0htMW1lZ1J6eHJHM2pUTmJHYlFsSGxfU3Q3QzNEejJTSUc2VjQ?oc=5\" target=\"_blank\">Press Release: Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">\u5bcc\u9014\u725b\u725b</font>", "publishedAt": "Wed, 13 Aug 2025 20:05:00 GMT"}, {"title": "Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates - Bluefield Daily Telegraph", "description": "<a href=\"https://news.google.com/rss/articles/CBMijgJBVV95cUxOSGpfWXN4YVI1bU15dVpsQmhMTG54MVF5b2w5dzFxdnBMREFHeWNSVWtsM2M2eW5uVEo1UnZXNGRPeXVScFdIQ19hbUF5anluM21EQ2JhS2hGYkF4NFVxcjZZY0dvMXpTZVN2b05pX09JQnNsdEdXalhfNWlyY1BkalM3eEI1WURsblYxSGk0NkE4bUJ6Y2dXU0NWeGVCTzhfamhBNWVfa1Rtb1g1YnN6ZGJVb3V5MS1uR19VWTREc3JqQkp3bnBkcXdVR0owcXRleWZjWkVsTVMxaTVMQ1dySFVkVFp2Uk9tcVIxa2FaTERNcm5xSHhfTTJUVl9vdmo3STEzQlA0ek4tYlF5eGc?oc=5\" target=\"_blank\">Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bluefield Daily Telegraph</font>", "publishedAt": "Wed, 13 Aug 2025 20:06:42 GMT"}, {"title": "Immuneering Corporation stock trendline breakdown - Earnings Growth Report & Consistent Profit Trading Strategies - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNSzBQYmY0S253RU9uZ0lUS2JORWR2Z2laR251QXNRdGwwV3k3d1NNRG1PZ2p6dU43S1JZX3hyNjNVclJ2dDc3dXZSNjZyUGE4RmZ4NHpuc3BLdWxONkVfdmpyU240TjdGaWlSYnJDNWNsOUpNOExhbmlLYi1oaFNYTnRGWlpRWS1zaDNv?oc=5\" target=\"_blank\">Immuneering Corporation stock trendline breakdown - Earnings Growth Report & Consistent Profit Trading Strategies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Fri, 15 Aug 2025 18:11:13 GMT"}, {"title": "Analysts Set Immuneering Corporation (NASDAQ:IMRX) Price Target at $13.25 - Defense World", "description": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxOTDR4N0dCYkVLSnktZzlOa2lzM1ZHenF5bkhwa3dERDNyNEVnemEzZHdhREwxblhyd2RuemU3UlczaWNUc0V3YkFJUzZ1YjJEeG5fZ0NRNkx6RzhReEJpbml1VGF5RmI1Y3J4WXJQcS1pVE9XeTYtRGNTamJrNW9hVlB1WjBQbFlsZktJdTBCZmhkaUNiWVNBLTZlUFJQQkpaRkZYSExFU2lGalZueFlyeUVLZXI?oc=5\" target=\"_blank\">Analysts Set Immuneering Corporation (NASDAQ:IMRX) Price Target at $13.25</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Defense World</font>", "publishedAt": "Wed, 13 Aug 2025 06:52:38 GMT"}, {"title": "Immuneering Corporation stock prediction for this week - 2025 Analyst Calls & Consistent Profit Trade Alerts - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPRjJjQVJPNERDSzMzck1ZbWtmV0NJUUN3eUlPZFRvV0xfc1RmMjhzc2x1bnRTeE5ONFdCaFlmQkx3bElSNUtjbVR6cmZjX21kd2ZpZmt0dDB3MkFBMldaYUJsazVPNG85TVBhVHlWenZLUEF4dS1maFBHdWtSaXpnVFhhVk9sZGRTVGw0?oc=5\" target=\"_blank\">Immuneering Corporation stock prediction for this week - 2025 Analyst Calls & Consistent Profit Trade Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Wed, 13 Aug 2025 10:19:16 GMT"}]